# Viridian Therapeutics, Inc.\\DE: Form 8-K, filed Jun 29, 2026

- Company: [Viridian Therapeutics, Inc.\\DE](/companies/vrdn.md) (CIK 1590750)
- Form: 8-K
- Filed: 2026-06-29
- Accepted by EDGAR: Jun 26, 2026, 18:18 ET
- Period: 2026-06-26
- Accession: 0001193125-26-286273
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590750/000119312526286273/d164211d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590750/000119312526286273/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1590750/000119312526286273/d164211d8k.htm

Filed Jun 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-286273. Last ingested by Listed: Nov 10, 2026, 17:36 ET. No prices; not investment advice.